GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
UBS Maintains Buy on Eli Lilly, Lowers Price Target to $1050
Eli Lilly Analyst Ratings
Catalyst Watch: Powell Presser, AMD Earnings, IBM Event, and Lions Gate Splits in Two
Novo Nordisk Says Oral Version of Wegovy Accepted for FDA Review
RBC Capital Maintains Outperform on Amgen, Lowers Price Target to $320
Amgen Analyst Ratings